首页/ 试剂/ T7-Scribe™ Standard RNA IVT Kit | C-AS3107 | CELLSCRIPT The T7-Scribe™ Standard RNA IVT Kit is specially formulated to enable users to obtain the maximum possible yields of canonical (GAUC) RNA from an in vitro transcription (IVT) reaction. The standard 2 hour, 20 μl reaction will yield up to 150 μg of RNA from 1 μg of the control template. These yields are made possible by the high-performance properties of the T7-Scribe enzyme. The T7-Scribe Standard RNA IVT Kit produces exceptionally high yields of either long or short transcripts. The standard reaction can be scaled up to produce milligram amounts of RNA. In addition, a T7-Scribe reaction can be readily modified to prepare fluorescent-, biotinylated- or digoxigenin-labeled RNA. T7-Scribe IVT RNA can be processed into mRNA (5\'-end capped and 3\'-end poly(A) tailed) through the use of CELLSCRIPT\'s ScriptCap™ m7G Capping System, ScriptCap 2\'-O-Methyltransferase Kit and A-Plus™ Poly(A) Polymerase Tailing Kit (available separately). CELLSCRIPT also offers the INCOGNITO™ line of transcription kits for the production of pseudouridine- 5-methyl-cytosine-containing (GA C and GA 5mC) IVT RNA. It has been shown that -mRNAs and 5mC-mRNAs are translated into protein at higher levels and induce lower innate immune responses in human and other mammalian cells that express various RNA sensors compared to corresponding unmodified mRNAs。CELLSCRIPT C-AS3107 品牌名称： CELLSCRIPTCELLSCRIPT C-AS3107 品牌logo：  CELLSCRIPT C-AS3107 品牌介绍：       CELLSCRIPT专注于再生医学，细胞再生学以及细胞疗法。细胞、组织或器官的移植治疗及修复中应用的细胞或生物体。CellScript还生产用于传递和翻译的合成修饰mRNA。        The mission of CELLSCRIPT™ is to provide the best products and technologies for making and using RNA for translation in cells for clinical research and therapeutics.        Current products include kits for in vitro transcription, 5\' RNA capping using either a cap analog or capping enzymes, and 3\' RNA polyadenylation, as well as all-in-one kits for making capped, poly(A)-tailed mRNA for translation in cells.        CELLSCRIPT™ recently introduced INCOGNITO™ RNA Transcription Kits for in vitrosynthesis of RNA that contains modified nucleosides, such as pseudouridine (Ψ) and/or 5-methylcytidine (m5C) in place of the corresponding U or C canonical nucleosides (Figure 1). These kits are so-named because the capped, polyadenylated and nucleoside-modified RNA products (called INCOGNITO mRNAs ) are disguised so they do not induce innate immune responses to the same extent as the corresponding unmodified mRNAs when transfected into mammalian cells that express a variety of RNA sensors.   No. 品牌 货号 名称 规格 1 CELLSCRIPT C-ACM04037 AmpliCap-Max™ T7 High Yield Message Maker Kit 25 rxns 2 CELLSCRIPT C-AC0706 AmpliCap™ SP6 High Yield Message Maker Kit 25 rxns 3 CELLSCRIPT C-C50110 Anti-Reverse Cap Analog (ARCA) 500 nmol 4 CELLSCRIPT C-CC15011H Cap-Clip™ Acid Pyrophosphatase 100 U 5 CELLSCRIPT C-ICSY110510 INCOGNITO™ SP6 Ψ-RNA Transcription Kit 10 rxns 6 CELLSCRIPT C-MSC100625 T7 mScript™ Standard mRNA Production System 25 rxns 7 CELLSCRIPT C-MMA60710 MessageMAX™ T7 ARCA-Capped Message Transcription Kit 10 rxns 8 CELLSCRIPT C-SRI6310K ScriptGuard™ RNase Inhibitor 10,000 U 9 CELLSCRIPT C-SCMT0610 ScriptCap™ 2\'-O-Methyltransferase Kit 10 rxns 10 CELLSCRIPT C-ICTY110510 INCOGNITO™ T7 Ψ-RNA Transcription Kit 10 rxns 11 CELLSCRIPT C-MMA60710 MessageMAX™ T7 ARCA-Capped Message Transcription Kit 10 rxns 12 CELLSCRIPT C-C61025 Monomethylated RNA Cap Analog 1,250 nmol 13 CELLSCRIPT C-PRM101125 PseudoU-RNA Molecular Weight Markers 25 lanes 14 CELLSCRIPT C-AS3106 SP6-Scribe™ Standard RNA IVT Kit 50 rxns 15 CELLSCRIPT C-PAP5104H A-Plus™ Poly(A) Polymerase Tailing Kit 50 rxns  CELLSCRIPT C-AS3107 品牌官网：http://www.cellscript.com CELLSCRIPT C-AS3107 联系方式：联系人：谢先生400电话：4009658633办公电话：010-56256916QQ：3212874516,3198592576网址：http://www.annoron.com/ CELLSCRIPT C-AS3107 产品相关链接：1 ADP P/N 3842 Collagen   P/N 3853 Thrombin P/N 3864 Arachidonic Acid P/N 3905 Epinephrine P/N 393  温馨提示：不可用于临床治疗。

风险提示：蚂蚁淘仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。